E-Learning

When I first invested in Nebius Group (NBIS) earlier this year, I approached it with cautious optimism—hyper-growth stocks carry inherent risk. Today, with the stock up over 50%, I remain confident and recently raised my 12-month price target to $60, implying further upside of over 50%. While its EV/Sales multiple above 50x may appear steep, it’s less relevant for a vertically integrated AI infrastructure leader positioned to capitalize on current momentum. In my view, Nebius remains one of the

You might not feel optimistic about the stock market right now, but Suze Orman is. Learn which types of investments she thinks are going to skyrocket this year.

APT shows resilience after sharp correction, with signs of accumulation emerging near $4.55 as traders eye recovery amid global economic uncertainty.

(Bloomberg) -- German Chancellor Friedrich Merz will travel to Washington for his inaugural meeting with US President Donald Trump next week, almost a month after starting his term leading Europe’s largest economy.

The decision to start investing is relatively easy, but it gets more complex after that. Find out why the investment fund you choose matters and how to decide.

(Bloomberg) -- The stock market’s crazy first five months of 2025 have left Wall Street pros in a bit of a pickle. Most Read from BloombergBillionaire Steve Cohen Wants NY to Expand Taxpayer-Backed FerryNow With Colorful Blocks, Tirana’s Pyramid Represents a Changing AlbaniaNYC Congestion Toll Brings In $216 Million in First Four MonthsThe Economic Benefits of Paying Workers to MoveWhere the Wild Children’s Museums AreComing off the best month for the S&P 500 Index in a year and a half and the b

Investors have a rare opportunity to invest in this leading coffee brand at a high yield. This is a great time to consider adding quality dividend stocks to your investment portfolio. While the near term could be rocky, investors who buy the following dividend stocks today could build up a rewarding stream of passive income for years to come.

Medtronic's diabetes care unit has grown faster than the rest of its business in recent years. Over the past few years, Medtronic (NYSE: MDT) has faced significant challenges, including a pandemic-induced slowdown, relatively slow revenue growth, and economic issues that impacted its financial results. Throughout it all, Medtronic's diabetes care business has consistently been one of its fastest-growing segments.

Apple has developed an ecosystem of tech devices that its customers love and are willing to trade up to have. American Express has numerous earnings streams, and a younger cohort of cardholders is driving growth. Coca-Cola's business has proven resilient under pressure, and it reliably boosts its dividends.

Demand for Japan’s 40-year government bonds plunged Wednesday to its lowest level since last July, reinforcing fears that appetite for ultra-long Japanese debt is evaporating.